New diabetes pill shows promise in real-world mexican study
NCT ID NCT05316662
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 24 times
Summary
This study looked at how the diabetes pill Rybelsus® (oral semaglutide) works in real life for adults with type 2 diabetes in Mexico. 187 participants took the medication as prescribed by their doctor and were followed for about 8-10 months. Researchers measured changes in blood sugar levels and body weight, and asked participants about their treatment experience.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CICEJ Centro de Investigacion Clinica Endocrinologica de Jalisco SC
Guadalajara, Jalisco, 44670, Mexico
-
Centro de Investigacion Clinica Endocrinologica de Jalisco
Guadalajara, Jalisco, 44670, Mexico
Conditions
Explore the condition pages connected to this study.